Results 171 to 180 of about 1,941,754 (312)
Return to Sport and High-Demanding Activities After Curettage for Benign and Locally Aggressive Bone Tumors. [PDF]
Ipponi E +8 more
europepmc +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
Global burden of pain in malignant bone tumors: a meta-analysis of severity and health outcomes. [PDF]
Zheng G +5 more
europepmc +1 more source
Conjugated poly(imide dioxime)‐based microspheres establish a radiometal coordination‐driven conformational interlocked network with ultra‐high radiostability. This platform enables low‐temperature, multi‐radionuclide labeling for SPECT/PET/MRI imaging and radionuclide therapy. Mechanistic insights from EXAFS and DFT reveal enhanced stability, while in
Xiao Xu +10 more
wiley +1 more source
Vitamin D decreases tumor cell growth and invasiveness in primary malignant bone tumors in vitro. [PDF]
Hein M +10 more
europepmc +1 more source
Acute growth of chondrosarcoma of the pelvis in a young male
Yue Xie, Jianmin Song
doaj +1 more source
A review of immunotherapy for bone tumors. [PDF]
Wang C, Chen Z, Mo H, Wang J, Zhou W.
europepmc +1 more source
In Situ Programmable Modulation of Hydrogel Stiffness for Stage‐Adaptive Bone Regeneration
Near‐infrared (NIR) irradiation triggers Ca2+ release from thermoresponsive nanocarriers, enabling in situ stiffening of an adaptive hydrogel from a soft to a stiff state, thereby sequentially supporting mesenchymal stromal cell stemness and osteogenic differentiation for stage‐adaptive bone regeneration.
Yuxin Yang +5 more
wiley +1 more source
Evaluation of ChatGPT-5.2 responses to frequently asked questions about benign bone tumors. [PDF]
Ayhan B, Yoğurt SB, Ayhan ZD.
europepmc +1 more source

